Thorsten Nowak
13Patents
5h-index
29Co-inventors
66Inventor score
Filing activity: Jan 28, 2000 → Mar 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6667342B1 | Benzenesulfonamide-derivatives and their use as medicaments | Chemistry; Metallurgy | 43 | Expired |
| US7579349B2 | 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer | Chemistry; Metallurgy | 16 | Expired |
| US10611760B2 | Therapeutic compounds as inhibitors of the orexin-1 receptor | Chemistry; Metallurgy | 8 | Active |
| US7795283B2 | Oxadiazole derivative as DGAT inhibitors | Chemistry; Metallurgy | 7 | Expired |
| US6458793B1 | Heterocyclic derivatives which inhibit factor Xa | Human Necessities | 6 | Expired |
| US6498275B1 | Use of compounds for the elevation of pyruvate dehydrogenase activity | Chemistry; Metallurgy | 4 | Expired |
| US6878712B1 | Amides as inhibitors for pyruvate dehydrogenase | Chemistry; Metallurgy | 4 | Expired |
| US6552225B1 | Chemical compounds | Chemistry; Metallurgy | 2 | Expired |
| US7799781B2 | 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors | Human Necessities | 1 | Active |
| US6689909B1 | Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | Chemistry; Metallurgy | 1 | Expired |
| US12098148B2 | Therapeutic compounds | Chemistry; Metallurgy | 0 | Active |
| US6960688B2 | Use of compounds for the elevation of pyruvate dehydrogenase activity | Chemistry; Metallurgy | 0 | Expired |
| US12024509B2 | Therapeutic compounds as inhibitors of the orexin-1 receptor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.